Ishita Drugs & Industries Peer Comparison

In the Pharmaceuticals & Drugs sector, Ishita Drugs & Industries Ltd. stands out for its unique position with no revenue or profit metrics reported, contrasting sharply with its peers who demonstrate varying degrees of financial performance and valuation. While some companies showcase strong profitability and growth, Ishita appears financially weak, suggesting a potential risk for investors. Companies like Sun Pharmaceutical and Dr. Reddy's display strong performance metrics, indicating they are sector leaders, while Ishita may need to improve its financial health to remain competitive.

• • Ishita Drugs has no reported revenue or profitability metrics.
• • Sun Pharmaceutical and Dr. Reddy's are leaders with strong growth and profitability.
• • Ishita Drugs is a financial outlier with no growth or profit, raising risk concerns.

• • Sun Pharmaceutical Industries Ltd.: Highest revenue growth of 8.42% YoY, strong EPS growth, and ROE of 16.13%.
• • Dr. Reddy's Laboratories Ltd.: High profitability with a PE ratio of 15.50 and strong growth metrics.